Professional Summary

Professional Overview

Laura Tong is a highly accomplished Senior Scientist with extensive expertise in the pharmaceutical and biotechnology industries. She specializes in innovative therapeutic research and development, leveraging her strong background in molecular biology, protein engineering, and preclinical studies.

Experience Summary

Current Role

As a Senior Scientist at Rondo Therapeutics, Laura is responsible for leading cross-functional research teams in the development of novel biotherapeutic candidates. In this role, she oversees all aspects of the research and discovery process, from target identification to advanced in vitro and in vivo studies. Her strategic leadership and technical acumen have been instrumental in driving the company's pipeline and delivering promising drug candidates.

Career Progression

Prior to joining Rondo Therapeutics, Laura held positions of increasing responsibility at leading biopharmaceutical companies. As a Scientist at Amgen, she made significant contributions to the company's oncology research program, where she played a critical role in the successful advancement of multiple drug candidates through preclinical development. Before that, she served as a Research Scientist at TeneoBio, Inc., where she specialized in the discovery and optimization of innovative antibody-based therapeutics.

Academic Background

Laura holds a Ph.D. in Molecular Biology from Stanford University, where her postdoctoral research focused on the development of novel protein engineering strategies for therapeutic applications. Her academic achievements include numerous peer-reviewed publications and presentations at prestigious scientific conferences.

Areas of Expertise

• Therapeutic protein design and engineering

• Antibody discovery and optimization

• Preclinical development and in vivo studies

• Target identification and validation

• Cross-functional team leadership and collaboration

Professional Impact

Throughout her career, Laura has demonstrated a track record of driving impactful research initiatives that have advanced the development of groundbreaking biotherapeutics. Her contributions have led to the successful progression of multiple drug candidates through the research and development pipeline, positively impacting the lives of patients in need.

Conclusion

With her exceptional scientific expertise, proven track record of success, and strong leadership skills, Laura Tong is poised to continue making significant contributions to the pharmaceutical and biotechnology industries. Her commitment to innovation and passion for developing transformative therapies make her a valuable asset to any organization.